Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q1 2025 Earnings Call Transcript
Operator: Hello and welcome to Adaptimmune's First Quarter 2025 Business Update Conference Call. As a reminder, all participants are in listen-only mode and the conference is being recorded.